Faculty profile

Alison Allan

Back to faculty

Associate Vice-President, Research & ProfessorDepartment of Anatomy & Cell BiologyWestern University

Alison Allan

Associate Vice-President, Research & Professor

Department of Anatomy & Cell Biology

Schulich School of Medicine & Dentistry

Western University

London, Ontario, Canada

Supervision signals

Professors usually supervise graduate students in their department's programs.
3 publications in the last five years, latest in 2026.
Principal investigator on 2 research grants (2 CIHR), most recently in 2020.
Supervised 4 trainees who won CIHR awards, most recently in 2024.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

439

Citations

h-index

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Profiles and links

University Profile Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Read how they describe their research on their Western University profile.

Breast Cancer Extracellular Vesicles Flow Cytometry Lung Microenvironment Metastasis Pre-Clinical Animal Models Proteomics Rnaseq

Latest papers

Single-cell genomic analysis of cancer cells from one treatment-naïve patient with metastatic prostate cancer.
BMC genomic data · 2026
Preclinical Studies on Mechanisms Underlying the Protective Effects of Propranolol in Traumatic Brain Injury: A Systematic Review
Journal of NeuroImmune Pharmacology · 2024
Exploitation of treatment induced tumor lysis to enhance the sensitivity of ctDNA analysis: A first-in-human pilot study.
Lung cancer (Amsterdam, Netherlands) · 2022

All 7 publications

Latest funding

Novel Mechanisms in Doxorubicin-induced Cardiomyopathy
CIHR · 2025 · Co-investigator
$100,000
Novel Mechanisms in Doxorubicin-induced Cardiomyopathy
CIHR · 2024 · Co-investigator
$100,000
Influence of breast cancer-derived extracellular vesicles on lung metastasis
CIHR · 2024 · Supervisor
$120,000

All 11 grants and awards

7 publications.

Single-cell genomic analysis of cancer cells from one treatment-naïve patient with metastatic prostate cancer.

Jovel J, Polzer B, Patterson J, Yong H, Vasquez C, O'keefe S, Pink D, Li G, Fairey A, Adam B, Teitelbaum J, Salimi A, Kirsh S, Alberter B, Lowes L, Carpenter E, Kolinsky M, Zhu Z, Zhou Q, Venner P, Venner C, Williams D, Allan A, Boutros PC, Klein CA, Wong G, Lewis JD

BMC genomic data2026

DOI: 10.1186/s12863-026-01435-5 PMID: 42098607

Preclinical Studies on Mechanisms Underlying the Protective Effects of Propranolol in Traumatic Brain Injury: A Systematic Review

Jae J, Li Y, Sun C, Allan A, Basmaji J, Chilton S, Simsam MH, Kao R, Owen A, Parry N

Journal of NeuroImmune Pharmacology20244 citations

DOI: 10.1007/s11481-024-10121-1

Exploitation of treatment induced tumor lysis to enhance the sensitivity of ctDNA analysis: A first-in-human pilot study.

Breadner DA, Vincent MD, Correa R, Black M, Warner A, Sanatani M, Bhat V, Morris C, Jones G, Allan A, Palma DA, Raphael J

Lung cancer (Amsterdam, Netherlands)2022

DOI: 10.1016/j.lungcan.2022.01.013 PMID: 35124411

Everolimus in Advanced Breast Cancer: A Systematic Review and Meta-analysis.

Raphael J, Lefebvre C, Allan A, Helou J, Boldt G, Vandenberg T, Blanchette PS

Targeted oncology2020

DOI: 10.1007/s11523-020-00770-6 PMID: 33151471

Stereotactic ablative radiotherapy for the comprehensive treatment of 1–3 Oligometastatic tumors (SABR-COMET-3): study protocol for a randomized phase III trial

Olson R, Mathews L, Liu M, Schellenberg D, Mou B, Berrang T, Harrow S, Correa RJM, Bhat V, Pai H

BMC Cancer2020125 citations

DOI: 10.1186/s12885-020-06876-4

Stereotactic ablative radiotherapy for the comprehensive treatment of 4–10 oligometastatic tumors (SABR-COMET-10): study protocol for a randomized phase III trial

Palma DA, Olson R, Harrow S, Correa RJM, Schneiders F, Haasbeek CJA, Rodrigues GB, Lock M, Yaremko BP, Bauman GS

BMC Cancer2019260 citations

DOI: 10.1186/s12885-019-5977-6

Canadian Cancer Trials Group IND197: a phase II study of foretinib in patients with estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2-negative recurrent or metastatic breast cancer

Rayson D, Lupichuk S, Potvin K, Dent S, Shenkier T, Dhesy-Thind S, Ellard SL, Prady C, Salim M, Farmer P

Breast Cancer Research and Treatment201650 citations

DOI: 10.1007/s10549-016-3812-1

Novel Mechanisms in Doxorubicin-induced Cardiomyopathy

Co-investigatorCIHR2025Project Grant - Priority Announcement - Breast Cancer Survivorship

Principal investigators: Singh, Krishna K; Hess, David A

Keywords: Breast Cancer Susceptibility Gene; Doxorubicin; Heart Failure

$100,000

Novel Mechanisms in Doxorubicin-induced Cardiomyopathy

Co-investigatorCIHR2024Project Grant - Priority Announcement - Breast Cancer Survivorship

Principal investigators: Singh, Krishna K; Hess, David A

Keywords: Breast Cancer Susceptibility Gene 2; Doxorubicin; Heart Failure

$100,000

Influence of breast cancer-derived extracellular vesicles on lung metastasis

SupervisorCIHR2024Doctoral Research Award: Canada Graduate Scholarships

Principal investigators: Patel, Urvi

Keywords: Angiogenesis; Breast Cancer; Extracellular Vesicles; Lung Metastasis; Pre-Metastatic Niche; Tipifarnib

$120,000

Novel Mechanisms in Doxorubicin-induced Cardiomyopathy

Co-investigatorCIHR2024Project Grant - Priority Announcement - Breast Cancer Survivorship

Principal investigators: Singh, Krishna K; Hess, David A

Keywords: Breast Cancer Susceptibility Gene 2; Doxorubicin; Heart Failure

$100,000

Studies of Anticancer Effects of Radiation Therapy and Polo-Like Kinase 4 (PLK4) Inhibitor CFI-400945 in Triple Negative Breast Cancer

Co-investigatorCIHR2022CIHR - ICR / Cancer Research Society Partnership - Res. Grants - Breast Cancer

Principal investigators: Parsyan, Armen

Keywords: Breast Cancer; Chemotherapy And Radiotherapy; Translational Research

$60,000

Influence of breast cancer-derived extracellular vesicles (BCEVs) on lung metastasis of triple negative breast cancer

Nominated PICIHR2020Project Grant

Principal investigators: Allan, Alison L

Keywords: Breast Cancer; Extracellular Vesicles; Flow Cytometry; Lung Microenvironment; Metastasis; Pre-Clinical Animal Models; Proteomics; Rnaseq; Tipifarnib; Triple Negative

$872,100

Analysis of Circulating Tumor Cell Heterogeneity Using a Multi-Marker Microscale Capture Approach as a tool in theManagement and Treatment of Cancer

Co-investigatorNSERC2016Collaborative Health Research Projects

Principal investigators: Kelley, Shana

$344,850

Molecular characterization of circulating tumor cells (CTCs) in prostate cancer.

SupervisorCIHR2011Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships

Principal investigators: Lowes, Lori E

Keywords: Cancer Stem Cells; Cd151; Cellsearch System; Circulating Tumor Cells; Epithelial-Mesenchymal Transition (Emt); Flow Cytometry; Fluorescence In Situ Hybridization; Molecular Characterization; Prostate Cancer

$105,000

Molecular Characterization of Circulating Tumour Cells in Breast and Prostate Cancer

SupervisorCIHR2010Master's Award: Canada Graduate Scholarships

Principal investigators: Lowes, Lori E

Keywords: Apoptosis Marker (M-30); Breast Cancer; Cancer Stem Cells; Cellsearch System; Circulating Tumor Cells; Flow Cytometry; Metastasis; Molecular Characterization; Prostate Cancer; Prostate-Specific Antigen

$17,500

Role of ALDH+/CD44+ stem-like cells in breast cancer progression and treatment

Nominated PICIHR2009CIHR New Investigator

Principal investigators: Allan, Alison L

Keywords: Aldh1; Breast Cancer; Cancer Stem Cells; Cd44; Metastasis; Response To Therapy

$300,000

From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.

Profile data last refreshed on November 9, 2025 from the university directory, publication records and CIHR, NSERC and SSHRC funding.

Something wrong or missing on this profile? Suggest a correction

Alison Allan

Research

Latest papers

Latest funding

Single-cell genomic analysis of cancer cells from one treatment-naïve patient with metastatic prostate cancer.

Preclinical Studies on Mechanisms Underlying the Protective Effects of Propranolol in Traumatic Brain Injury: A Systematic Review

Exploitation of treatment induced tumor lysis to enhance the sensitivity of ctDNA analysis: A first-in-human pilot study.

Everolimus in Advanced Breast Cancer: A Systematic Review and Meta-analysis.

Stereotactic ablative radiotherapy for the comprehensive treatment of 1–3 Oligometastatic tumors (SABR-COMET-3): study protocol for a randomized phase III trial

Stereotactic ablative radiotherapy for the comprehensive treatment of 4–10 oligometastatic tumors (SABR-COMET-10): study protocol for a randomized phase III trial

Canadian Cancer Trials Group IND197: a phase II study of foretinib in patients with estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2-negative recurrent or metastatic breast cancer

Novel Mechanisms in Doxorubicin-induced Cardiomyopathy

Novel Mechanisms in Doxorubicin-induced Cardiomyopathy

Influence of breast cancer-derived extracellular vesicles on lung metastasis

Novel Mechanisms in Doxorubicin-induced Cardiomyopathy

Studies of Anticancer Effects of Radiation Therapy and Polo-Like Kinase 4 (PLK4) Inhibitor CFI-400945 in Triple Negative Breast Cancer

Influence of breast cancer-derived extracellular vesicles (BCEVs) on lung metastasis of triple negative breast cancer

Analysis of Circulating Tumor Cell Heterogeneity Using a Multi-Marker Microscale Capture Approach as a tool in theManagement and Treatment of Cancer

Molecular characterization of circulating tumor cells (CTCs) in prostate cancer.

Molecular Characterization of Circulating Tumour Cells in Breast and Prostate Cancer

Role of ALDH+/CD44+ stem-like cells in breast cancer progression and treatment

Frequent collaborators

Devin Schellenberg

Stewart Gaede

Anand Swaminath

Robert Olson

Michael Kolinsky

Kelly Vogt

Ian Ball

Neil Parry

Shane Smith

Bram Rochwerg

Christopher Venner

Ming-Sound Tsao

Sukhbinder Dhesy-Thind

Adrian Owen

Alison Allan

Research

Latest papers

Latest funding

Single-cell genomic analysis of cancer cells from one treatment-na&#xef;ve patient with metastatic prostate cancer.

Preclinical Studies on Mechanisms Underlying the Protective Effects of Propranolol in Traumatic Brain Injury: A Systematic Review

Exploitation of treatment induced tumor lysis to enhance the sensitivity of ctDNA analysis: A first-in-human pilot study.

Everolimus in Advanced Breast Cancer: A Systematic Review and Meta-analysis.

Stereotactic ablative radiotherapy for the comprehensive treatment of 1–3 Oligometastatic tumors (SABR-COMET-3): study protocol for a randomized phase III trial

Stereotactic ablative radiotherapy for the comprehensive treatment of 4–10 oligometastatic tumors (SABR-COMET-10): study protocol for a randomized phase III trial

Canadian Cancer Trials Group IND197: a phase II study of foretinib in patients with estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2-negative recurrent or metastatic breast cancer

Analysis of Circulating Tumor Cell Heterogeneity Using a Multi-Marker Microscale Capture Approach as a tool in theManagement and Treatment of Cancer

Frequent collaborators

Devin Schellenberg

Stewart Gaede

Anand Swaminath

Robert Olson

Michael Kolinsky

Kelly Vogt

Ian Ball

Neil Parry

Shane Smith

Bram Rochwerg

Christopher Venner

Ming-Sound Tsao

Sukhbinder Dhesy-Thind

Adrian Owen

Single-cell genomic analysis of cancer cells from one treatment-naïve patient with metastatic prostate cancer.